The novel treatment of the medication represents a exciting advance in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – leading to enhanced blood sugar control and potential weight loss. Researchers are stu